Mrsa cprr testing and service
Ended Awarded Last action
- Contract number
- 36C25225N0092
- Awardee
-
Cepheid UEI W6HQTMWB9Q28
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $45,043
Award facts
- Contract value 100% obligated
- $45,042.96 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Funding agency
- Veterans Integrated Service Network 10 Veterans Health Administration, Department of Veterans Affairs
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Competition
- Not Competed Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Sunnyvale, CA 94089, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | -$269 | |
| Original award | $45,312 |
About this award
The Department of Veterans Affairs' Veterans Integrated Service Network 10 awarded a $45,042.96 firm fixed-price delivery order to Cepheid Inc. for Methicillin-resistant Staphylococcus aureus (MRSA) testing and service. The contract, awarded on October 1, 2024, with an ultimate completion date of September 30, 2025, represents a continuation of Cepheid's established role as a primary supplier of molecular diagnostic solutions to the VA system. The work will be performed at Cepheid's facility in Sunnyvale, California. This delivery order carries no set-aside designation and falls within Cepheid's broader federal contract portfolio focused on infectious disease diagnostics.
This award is likely associated with one of Cepheid's significant Indefinite Delivery Vehicle contracts with the VA, which provide the framework for ongoing procurement of molecular diagnostic testing systems and reagents. Cepheid's core GeneXpert diagnostic platform and associated test kits are widely deployed across VA networks for rapid detection and identification of infectious pathogens, including MRSA, which is a priority pathogen in healthcare settings due to its antimicrobial resistance profile. The firm fixed-price structure and modest ceiling value reflect the standardized nature of diagnostic testing services and reagent supply within the VA's established healthcare operations.
Quick answers
Who was awarded contract 36C25225N0092?
36C25225N0092 was awarded to Cepheid by Veterans Integrated Service Network 12 (Veterans Health Administration) on October 1, 2024.
How much is contract 36C25225N0092 worth?
The government has obligated $45,043 on 36C25225N0092.
Which agency awarded contract 36C25225N0092?
Veterans Integrated Service Network 12 (Veterans Health Administration) awarded 36C25225N0092, with funding from Veterans Integrated Service Network 10 (Veterans Health Administration).
Is contract 36C25225N0092 an order under another contract?
Yes. 36C25225N0092 is a delivery order under 36C25223D0075, an indefinite delivery contract.
Was contract 36C25225N0092 competed?
The extent of competition for 36C25225N0092 was not competed.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award